130 related articles for article (PubMed ID: 36199201)
1. A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study.
Bachhav SS; Taylor M; Martin A; Green JA; Duparc S; Rolfe K; Sharma H; Tan LK; Goyal N
Br J Clin Pharmacol; 2023 Mar; 89(3):1187-1197. PubMed ID: 36199201
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial.
Thakkar N; Green JA; Koh GCKW; Duparc S; Tenero D; Goyal N
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201820
[TBL] [Abstract][Full Text] [Related]
3. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Vélez ID; Hien TT; Green JA; Martin A; Sharma H; Rousell VM; Breton JJ; Ernest TB; Rolfe K; Taylor M; Mohamed K; Jones SW; Chau NH; Hoa NT; Duparc S; Tan LK; Goyal N
Lancet Child Adolesc Health; 2022 Feb; 6(2):86-95. PubMed ID: 34871570
[TBL] [Abstract][Full Text] [Related]
4. Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound.
Goyal N; Mohamed K; Rolfe K; Sahota S; Ernest T; Duparc S; Taylor M; Casillas L; Koh GCKW
AAPS J; 2018 Jun; 20(4):74. PubMed ID: 29869298
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects.
Charles BG; Miller AK; Nasveld PE; Reid MG; Harris IE; Edstein MD
Antimicrob Agents Chemother; 2007 Aug; 51(8):2709-15. PubMed ID: 17517850
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
Edstein MD; Kocisko DA; Brewer TG; Walsh DS; Eamsila C; Charles BG
Br J Clin Pharmacol; 2001 Dec; 52(6):663-70. PubMed ID: 11736877
[TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic study of radiprodil oral suspension in healthy adults comparing conventional venous blood sampling with two microsampling techniques.
Sciberras D; Otoul C; Lurquin F; Smeraglia J; Lappert A; De Bruyn S; Jaap van Lier J
Pharmacol Res Perspect; 2019 Feb; 7(1):e00459. PubMed ID: 30705758
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling.
Gustavsen MT; Midtvedt K; Vethe NT; Robertsen I; Bergan S; Åsberg A
Ther Drug Monit; 2020 Jun; 42(3):407-414. PubMed ID: 31479042
[TBL] [Abstract][Full Text] [Related]
11. Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.
Vuong C; Xie LH; Potter BM; Zhang J; Zhang P; Duan D; Nolan CK; Sciotti RJ; Zottig VE; Nanayakkara NP; Tekwani BL; Walker LA; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Smith B; Marcsisin SR
Antimicrob Agents Chemother; 2015 Jul; 59(7):3864-9. PubMed ID: 25870069
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
Miller AK; Harrell E; Ye L; Baptiste-Brown S; Kleim JP; Ohrt C; Duparc S; Möhrle JJ; Webster A; Stinnett S; Hughes A; Griffith S; Beelen AP
Br J Clin Pharmacol; 2013 Dec; 76(6):858-67. PubMed ID: 23701202
[TBL] [Abstract][Full Text] [Related]
13. Utility of capillary microsampling for rat pharmacokinetic studies: Comparison of tail-vein bleed to jugular vein cannula sampling.
Korfmacher W; Luo Y; Ho S; Sun W; Shen L; Wang J; Wu Z; Guo Y; Snow G; O'Shea T
J Pharmacol Toxicol Methods; 2015; 76():7-14. PubMed ID: 26164093
[TBL] [Abstract][Full Text] [Related]
14. Microsampling to support pharmacokinetic clinical studies in pediatrics.
Guerra Valero Y; Dorofaeff T; Parker L; Coulthard MG; Sparkes L; Lipman J; Wallis SC; Roberts JA; Parker SL
Pediatr Res; 2022 May; 91(6):1557-1561. PubMed ID: 34023854
[TBL] [Abstract][Full Text] [Related]
15. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
16. Tafenoquine: First Global Approval.
Frampton JE
Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
[TBL] [Abstract][Full Text] [Related]
17. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
[TBL] [Abstract][Full Text] [Related]
20. Tafenoquine: a promising new antimalarial agent.
Crockett M; Kain KC
Expert Opin Investig Drugs; 2007 May; 16(5):705-15. PubMed ID: 17461742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]